Asia Pacific Orthopedic Biomaterial Market Size and Trend by 2023; S&V Technologies, Rayner, Covestro, Invibio Ltd. and More

Biomaterials are used in the orthopedic treatment. Being inert in nature they are used in the manufacturing of different implants. Many medical implants such as dental implants, knee and hip implants, heart valves and others are prepared by biomaterials. Increasing number of orthopedic surgeries, increasing geriatric population in countries like India and China, increasing prevalence of diseases such as arthritis and osteoporosis have also contributed to the growth of the market. Introduction of titanium implants has minimized the failure of the treatment, which drive the market. High cost of treatment, long approval time for the products, and stringent regulatory laws may hamper the growth of the market over the corresponding period.

The Asia Pacific Orthopedic Biomaterial Market is expected to grow at a CAGR of 12.6% during the forecasted period 2017-2023.

Key Players

Some of the major players in the Asia Pacific orthopedic biomaterial market are Kyocera Corporation (Japan), Materion Corporation (US), S&V Technologies (Germany), Rayner (UK), InVision Biomedical (US), Covestro (Germany), Invibio Ltd. (U.K.), Royal DSM (Netherlands), BASF SE (Germany), Corbion N.V. (Netherlands), CeramTec (Germany), Tianjin Walkman Biomaterial Co. (China), Kanghui Holdings (China), Johnson & Johnson Services, Inc. (US), Cam Bioceramics B.V. (Netherland), Xian Airfoil Technology Co (China).

Since the cost of the orthopedic biomaterial treatment is high, many manufacturers are focusing on introducing the better and the cost-effective product in the market. Acquisitions, collaborations, and new product launch and expansion are major strategies adopted by some of the players to achieve growth in this market.

Royal DSM, a Dutch multinational company, is active in nutrition, health and materials headquartered in Netherlands. Dyneema Purity is the leading material for use in high-strength orthopedic sutures by the company. Bionate, CarboSil are some of the common polyurethanes manufactured by the company. In 2015, Royal DSM has acquired Cubic Tech.

Access Sample Copy @ https://www.marketresearchfuture.com/sample_request/643 .

Materion Corp., the US headquartered multinational company, is specialized in the development of high performance engineered materials. Trident and accolade are the hip implants manufactured by the company.

Regional Analysis

China dominates the Asia Pacific orthopedic biomaterial market owing to increasing prevalence of different orthopedic surgeries in China. Increasing awareness of biodegradable products among the people, rapid research and development and huge aging population in this region have added fuel to the growth of the market. Japan and Australia are other major contributor of the market in this region.

Brief TOC

1 Report Prologue

2 Market Introduction

2.1 Introduction
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations

Get Attractive Discount @ https://www.marketresearchfuture.com/check-discount/643 .

3 Research Methodology

3.1 Research Process
3.2 Primary Research
3.3 Secondary Research

4 Market Dynamics

….Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.